iRhythm 10-Q: Q3 Revenue $221.6M, $49.8M Litigation Hit, New $300M Revolver
IRTC is trading near its 52-week low of $100.7 (9.2% above the low).
Summary
iRhythm's Q3 10-Q confirms $221.6M revenue (up 15%) but shows a $49.8M litigation settlement charge pushing GAAP net loss to $0.90 per share, and discloses a new undrawn $300M revolving credit facility.
Key Events · Earnings and Guidance · IRTC
-
Q3 Revenue Grows 15% to $221.6M
Revenue rose to $221.6M from $192.9M a year earlier on higher Zio monitor and Zio AT volumes; nine-month revenue was $645.2M, up 20%.
-
$49.8M Litigation Charge Drives GAAP Loss
Q3 litigation settlement expense of $49.8M (the $50.0M Baxter patent payment) pushed net loss to $29.9M, or $0.90 per share, versus a $5.2M loss a year ago; adjusted EBITDA was still $51.2M.
-
New $300M Undrawn Revolving Credit Facility
Signed November 3, 2026 with JPMorgan as administrative agent, maturing November 3, 2031 with a springing maturity tied to the 2029 Notes; no amounts borrowed at closing.
-
Liquidity: $394.7M Cash Plus $166.0M Securities
Cash and equivalents of $394.7M and marketable securities of $166.0M at September 30, 2026; nine-month operating cash flow fell to $29.3M from $54.7M due to the $50.0M Baxter payment.
Analysis · IRTC · Industrial Applications And Services
The 10-Q confirms the Q3 numbers already released the same day but fills in what the 8-K did not. A $49.8M litigation settlement charge in the quarter (the $50.0M Baxter patent payment) dragged GAAP net loss to $29.9M, or $0.90 per share, versus a $5.2M loss a year ago. Underneath that one-time item, gross margin improved to 74% and adjusted EBITDA reached $51.2M. The company also disclosed a new $300M senior secured revolving credit facility signed November 3, 2026, undrawn at closing, which adds liquidity alongside $394.7M of cash and $166.0M of marketable securities. Nine-month operating cash flow fell to $29.3M from $54.7M because of the Baxter payment. The unresolved DOJ matter remains the main overhang, with a November 4, 2026 meeting held to discuss resolution pathways.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IRTC was trading at $110.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $100.70 to $192.47. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.